EGC have a risk of developing a second primary (metachronous) cancer, such as colorectal, lung, or liver cancer [1][2][3].The duodenal stump after Billroth II (B-II) distal gastrectomy is a rare site for cancer recurrence unless a tumor-free margin has not been achieved. Moreover, to our knowledge, there are no previously published studies regarding the occurrence of recurrent or metachronous cancer at the duodenal stump. Here, we describe duodenal stump cancer that occurred after a B-II distal gastrectomy for advanced gastric cancer (AGC), particularly focusing on the diffi culties associated with distinguishing recurrent gastric cancer from metachronous duodenal cancer.
Case reportA 68-year-old man who had undergone distal gastrectomy with B-II type gastrojejunostomy for AGC in June 2005, presented with abrupt onset of dizziness and tarry stool in June 2008. The previously removed tumor was 8.5 × 7.5 cm in size, and located in the posterior wall of the mid-body portion of the stomach, and there was no duodenal lesion on the gastrofi berscopic (GFS) examination that had been performed before the gastrectomy. Pathologic examination revealed that the gastric lesion was a poorly differentiated adenocarcinoma infi ltrating the subserosa, accompanied by multiple lymph node metastases (48 of 77 retrieved nodes were metastatic); the duodenum was resected, using a linear stapler, about 2 cm below the pyloric ring. The proximal and distal resected margins were 1.5 cm and 8.0 cm, respectively. Subsequently, six cycles of adjuvant chemotherapy, including 5-fl uorouracil (FU), epirubicin, and cisplatinum, were performed without any problems. The patient was followed up every 6 months by tumor marker analysis, ultrasonography, and computed tomography (CT) and his last checkup had been in January 2008. During Abstract Duodenal cancer is an uncommon neoplasm and it mostly arises from the periampullary area. However, metachronous or even recurrent cancer at the duodenal stump following Billroth II type distal gastrec tomy for gastric cancer is extremely rare and, to our knowledge, has not yet been reported. A 68-year-old man underwent Billroth II distal gastrectomy with D2 lymph node dissection for an advanced gastric cancer. At that time the tumor stage was T2bN3M0, with 44 of 78 retrieved lymph nodes showing metastasis. He was well without recurrence for 3 years; however, he visited our hospital because of the abrupt onset of dizziness and tarry stool. A polypoid tumor that bled easily when touched was found at the end of the afferent loop of the duodenal stump by gastrofi berscopic examination, and it was proven to be an adenocarcinoma by endoscopic biopsy. Fortunately, additional studies, including abdominal computed tomography and positron emission tomography-computed tomography, showed no other sites of recurrence. The patient underwent pancreaticoduodenectomy for local control of the recurrent tumor at the duodenal stump, and the pathologic fi ndings, based on immunohistochemical staining, strongly suggested that the du...